I can’t think of a better-prepared, pragmatic and caring executive to join the Board.
WASHINGTON (PRWEB) May 29, 2018
Mr. Rosendale brings more than three decades of relevant technology and life sciences leadership experience to the MTC Board where he joins a distinguished and diverse group of executives from the private sector, public sector, academia, not-for-profit and NGO sectors who guide and support the management and staff of MTC as the State’s unified voice for attracting tech and life science companies and leveraging synergies to solidify Maryland as an elite hub. In 2016, Mr. Rosendale was engaged by the Board to assist with the merger of the Technology Council of Maryland and the Chesapeake Regional Tech Council which was celebrated by Maryland Governor Larry Hogan who stated that the merger demonstrated the “the collective strength and impact of Maryland’s tech sector which is growing every day with new startups and expansions by our companies.”
MTC Chairman Rene B. LaVigne, President & Chief Executive Officer of Iron Bow Technologies said “Mr. Rosendale served the Tech Council of Maryland at a critical time and played an integral role in the merger of the two organizations. When the Tech Council was facing its most significant challenges, Marty’s leadership, diligence and commitment to the Council and its membership was absolutely invaluable.”
“I am pleased to be elected to the Board of the Maryland Technology Council, and to have a leadership role in the critical mission to support Maryland companies that are focused on saving lives, securing our nation, and improving the quality of life through innovation,” said Marty Rosendale. Mr. Rosendale added, “Maryland is the center of Life Sciences in the BioHealth Capital Region. The world depends on what we do.”
The Maryland Technology Council is the largest Life Science and Technology industry organization in Maryland with over 600 members representing the biotechnology, therapeutics, medical devices, cyber security, and technology industries.
“Marty Rosendale cares deeply about Life Sciences and the potential to save and improve lives said Tony Cord, Managing Director of Newport’s Mid-Atlantic Region. He speaks authoritatively as a 35-year veteran and subject matter expert, and is passionate as an advocate for supporting the missions of all companies whose technologies are intended to save and improve lives. I can’t think of a better-prepared, pragmatic and caring executive to join the Board,” he added.
Prior to joining Newport, and leading its Life Sciences Practice, he was the founder and CEO of Selnova LLC, a professional services firm dedicated to supporting life science companies. Marty has led several successful businesses in various market sectors including medical biologics, drugs, medical devices, and plastics. He has launched, branded, acquired or commercialized more than 10 products and companies. He has been a Board member for Nuo Therapeutics, the Transplant Recipients International Organization and the American Red Cross, San Jose Region, and Marty is a founder and Management Committee member of The Maryland Tech Council Venture Mentoring Service.
Mr. Rosendale and his family reside in Mt. Airy, MD.
Newport Board Group is a unique national professional services firm of CEOs, senior executives and board members who collaborate to serve emerging growth and entrepreneurial middle market companies and the private equity firms that invest in them. By working together in local practices in major cities and across the country, Newport partners create solutions to help clients improve their performance and valuation and become more transaction-ready.
Mark Rosenman, Chief Knowledge Officer - mark.rosenman@newportboardgroup.com or 973.509.3838